Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms — Recommendations for Clinical Evaluation
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 31, 2003
March 13, 2019
729d676c-05c7-4f9b-bfcd-77ed841b485f
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Mpox: Development of Drugs and Biological Products; Guidance for Industry
Guidance DocumentJanuary 19, 2023Center for Drug Evaluation and Research
Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 13, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.